Search results
Results from the WOW.Com Content Network
Hydrochlorothiazide, sold under the brand name Hydrodiuril among others, is a diuretic medication used to treat hypertension and swelling due to fluid build-up. [4] Other uses include treating diabetes insipidus and renal tubular acidosis and to decrease the risk of kidney stones in those with a high calcium level in the urine. [4]
In a phase III double-blind, randomized, controlled trial supported by Eli Lilly, nondiabetic adults with a body mass index of 30 or more, or 27 or more and at least one weight-related complication, excluding diabetes, were randomized to receive once-weekly, subcutaneous tirzepatide (5 mg, 10 mg, or 15 mg) or placebo. The mean percentage change ...
The first approved drug of this class, chlorothiazide, was marketed under the trade name Diuril beginning in 1958. [3] In most countries, thiazides are the least expensive antihypertensive drugs available. [4] Thiazide organic molecules are bi-cyclic structures that contain adjacent sulfur and nitrogen atoms on one ring. [5]
The Food and Drug Administration ... 22.5% of participants taking 84 milligram (mg) doses of Spravato achieved MDD remission with an MADRS total score of less than or equal to 12, and 18.3% of ...
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit [3] [note 1] N/A Not more than 100 milligrams of opium per 100 milliliters or per 100 grams [3] [note 1] N/A Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit [4]
0.5: 0.5–2: 2: hypnotic: Drug Name Common Trade Names Year Approved Typical Dosages of Oral Tablets (mg) Approx. Equivalent Oral Dose to 10mg Diazepam (mg) Peak onset of action (hours) Elimination Half-life of Active Metabolite (hours) Primary Therapeutic Use
In those taking sulphonylureas there is an increased risk of low blood sugar. [8]3 adverse reactions were seen higher in saxagliptin vs placebo. Table 1: Adverse Reactions (Regardless of Investigator Assessment of Causality) in Placebo-Controlled Trials* Reported in ≥ 5% of Patients Treated with ONGLYZA (saxagliptin tablets) 5 mg and More Commonly than in Patients Treated with Placebo.
The California School Food Safety Act, which is a follow-up to the California Food Safety Act and focuses on foods served in schools, will ban red dye No. 40, yellow dyes Nos. 5 and 6, blue dyes ...